医学
血液透析
终末期肾病
血栓形成
抗血栓
动静脉瘘
透析
重症监护医学
肾脏疾病
终末期肾病
血液透析导管
抗凝剂
内科学
血管通路
维生素K拮抗剂
外科
华法林
心房颤动
作者
David E. Kearney,Amanda K. Leonberg‐Yoo,Raphael M. Cohen
摘要
Abstract Vascular access thrombosis (VAT) is common among patients receiving hemodialysis and leads to missed dialysis treatments, hospitalizations, catheter placement, and graft/fistula abandonment. This article reviews the association between hypercoagulability and VAT and the high prevalence of hypercoagulable states in end‐stage kidney disease (ESKD). This article reviews the role of antithrombotic and anticoagulant medications in preventing VAT. The article concludes by reviewing the unique challenges of using vitamin K antagonists in patients with ESKD.
科研通智能强力驱动
Strongly Powered by AbleSci AI